您的位置: 首页 > 农业专利 > 详情页

COMBINATION THERAPIES FOR ERADICATING FLAVIVIRUS INFECTIONS IN SUBJECTS
专利权人:
Temple University - of the Commonwealth System of Higher Education
发明人:
Kamel Khalili,Ilker K. Sariyer,Hassen Wollebo
申请号:
US16341481
公开号:
US20190365862A1
申请日:
2017.10.12
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Compositions that specifically cleave target sequences in Flavivirus, for example Zika virus include a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) associated endonuclease, a guide RNA sequence complementary to a target sequence in a Zika virus and an anti-viral agent. These compositions are administered to a subject for treating an infection or at risk for contracting a Zika virus infection.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充